NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Redx Pharma Plc

Redx Pharma Plc

Private
MacclesfieldHealthcare & Life Scienceshttps://www.redxpharma.com/

Last Round

Private Placement

Oct 18, 2023

Est. Valuation

$30.03M

Total Funding Raised

$63.59M

Company Overview

Redx Pharma Plc is a clinical-stage biotechnology company that discovers and develops novel, small molecule, targeted medicines for the treatment of fibrotic disease and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

small molecule drugsdrug discoverypharma licensingfibrotic disease therapeuticsoncology therapeuticsROCK2 inhibitoridiopathic pulmonary fibrosisIPFclinical-stage biotechPorcupine inhibitorbiotech partnershipsmedicinal chemistrydrug development pipelineKRAS inhibitorspan-RAF inhibitorfibrostenotic Crohn's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redx Pharma Plc Comps

Public and private peers based on sector, stage, and business model.

Redx Pharma Plc comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Redx Pharma Plc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementOct 18, 2023
Private PlacementJun 7, 2022
Follow-on OfferingDec 21, 2020
Convertible DebtAug 4, 2020
Private PlacementJul 21, 2020
Private Placement
Mar 4, 2020

Key People

Founding team and executive leadership

Lisa Anson

Chief Executive Officer

Executive Team

Peter Collum

Chief Financial Officer

Executive Team

James Mead

Chief Operating Officer

Executive Team

Redx Pharma Plc Investors

Notable investors and investment history

Redx Pharma Plc investors
InvestorRounds
Redmile GroupFollow-on Offering, Private Placement, Convertible Debt
Polar CapitalPrivate Placement, Follow-on Offering
Platinum Asset ManagementPrivate Placement
Sofinnova PartnersFollow-on Offering, Private Placement, Convertible Debt
InvusPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 50% MoM, reaching 6.6K.

  • Feb 23, 2025

    Monthly visitors increased 36% MoM, reaching 5.3K.

Redx Pharma Plc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Redx Pharma Plc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redx Pharma Plc's valuation, stock price, and market status.

Firmographic Details

HeadquartersMacclesfield
Employee Range39
Year Founded2010
Last FundingOct 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.